Bo Zhuang
Bo Zhuang has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Caixia Xu
Institute of NBC Defense
2 shared publicationsLiang Zong
Institute of NBC Defense
2 shared publications- Weihui Wu
Institute of Chemical Defence, Beijing, 102205, China
2 shared publications Yanhua Xiao
Institute of NBC Defense
2 shared publications- Yiguang Jin
Academy of Military Medical Sciences, Beijing 100850, China
2 shared publications - Bin Feng
College of Basic Medical Science, Dalian Medical University, China
1 shared publication
Latest Publications
- 17 February 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (3) , 2439-2450
“One-Stone, Three-Birds”: Discrimination of Triple Chemical Threats in Both Solution and Vapor Phases on a Single AIEgen Platform by Exploiting an Electrophilicity Gradient
The discriminative detection of multiple chemical threats remains a formidable challenge for conventional molecular probes. Herein, we report a versatile sensing platform that achieves unambiguous identification of nerve agents, phosgene, and oxalyl chloride in both solution and vapor phases by capitalizing on their inherent electrophilicity gradient. The system integrates an AIE-active hydroxamic acid probe (TPE-HOA) with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), where DBU acts not merely as a base but as a key discriminatory component. This synergistic combination enables a kinetic competition strategy that directs each analyte toward a distinct optical pathway. In solution, oxalyl chloride triggers a rapid colorimetric change, while phosgene and nerve agents are differentiated via precipitate formation and fluorogenic kinetics. On test strips, vapor discrimination is accomplished by monitoring time-dependent fluorescence profiles and employing phosgene as a diagnostic reagent. Critically, the platform's efficacy is demonstrated with authentic nerve agents (VX, sarin), phosgene, and oxalyl chloride, underscoring its practical utility. This work establishes a new "reactivity-based discrimination" paradigm for the development of advanced multi-analyte sensing systems.
- 17 February 2026
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 11 (3) , 2439-2450
“One-Stone, Three-Birds”: Discrimination of Triple Chemical Threats in Both Solution and Vapor Phases on a Single AIEgen Platform by Exploiting an Electrophilicity Gradient
The discriminative detection of multiple chemical threats remains a formidable challenge for conventional molecular probes. Herein, we report a versatile sensing platform that achieves unambiguous identification of nerve agents, phosgene, and oxalyl chloride in both solution and vapor phases by capitalizing on their inherent electrophilicity gradient. The system integrates an AIE-active hydroxamic acid probe (TPE-HOA) with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), where DBU acts not merely as a base but as a key discriminatory component. This synergistic combination enables a kinetic competition strategy that directs each analyte toward a distinct optical pathway. In solution, oxalyl chloride triggers a rapid colorimetric change, while phosgene and nerve agents are differentiated via precipitate formation and fluorogenic kinetics. On test strips, vapor discrimination is accomplished by monitoring time-dependent fluorescence profiles and employing phosgene as a diagnostic reagent. Critically, the platform's efficacy is demonstrated with authentic nerve agents (VX, sarin), phosgene, and oxalyl chloride, underscoring its practical utility. This work establishes a new "reactivity-based discrimination" paradigm for the development of advanced multi-analyte sensing systems.
- Top Cited Papers
- 12 October 2024
- Published by Elsevier in Biomaterials
- Vol. 314, 122891
In situ photocrosslinkable hydrogel treats radiation-induced skin injury by ROS elimination and inflammation regulation
- 12 October 2024
- Published by Elsevier in Biomaterials
- Vol. 314, 122891
Top Cited PapersIn situ photocrosslinkable hydrogel treats radiation-induced skin injury by ROS elimination and inflammation regulation
- 22 July 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (7) , 260
3D-Printed Wearable Personalized Orthodontic Retainers for Sustained Release of Clonidine Hydrochloride
Orthodontic retainers are wearable customizable medical devices for dental protection or alignment. Here, clonidine hydrochloride (CH)-loaded wearable personalized 3D printed orthodontic retainers were studied for local sustained-release of drugs. CH powders were mixed with PEG 4000, Tween 80, poly(lactic acid), and polycaprolactone. The mixture was hot-melt extruded to form a filament that was 3D printed to a customizable original orthodontic retainer with the fused deposition modeling (FDM) method. The original retainer showed a burst release of CH in the early stage of the dissolution process though a sustained release appeared in the late stage. The in vivo burst release of CH would lead to unexpected side effect. The original retainer was modified by coating with hydrophilic polymers or washing with buffered solutions to obtain the coated or washed retainer. The coated retainer still showed a burst release while the washed retainer showed an optimal sustained release. Many CH microparticles existed on the surface of original retainers according to the scanning electron microscopic image so that the burst release was unavoidable. The hydrophilic polymer coating method did not change the release profile because the polymer was also rapidly dissolved. However, most of the surface CH can be eliminated by washing so that the burst release dissappeared in the washed retainer. Furthermore, the simulated CH concentration-time profiles in the circulation of humans of the washed retainer showed the stable and appropriate drug levels for more than 3 days. Wearable personalized 3D printed drug-loaded orthodontic retainers are a promising drug-device for sustained release of drugs.
- 22 July 2019
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (7) , 260
3D-Printed Wearable Personalized Orthodontic Retainers for Sustained Release of Clonidine Hydrochloride
Orthodontic retainers are wearable customizable medical devices for dental protection or alignment. Here, clonidine hydrochloride (CH)-loaded wearable personalized 3D printed orthodontic retainers were studied for local sustained-release of drugs. CH powders were mixed with PEG 4000, Tween 80, poly(lactic acid), and polycaprolactone. The mixture was hot-melt extruded to form a filament that was 3D printed to a customizable original orthodontic retainer with the fused deposition modeling (FDM) method. The original retainer showed a burst release of CH in the early stage of the dissolution process though a sustained release appeared in the late stage. The in vivo burst release of CH would lead to unexpected side effect. The original retainer was modified by coating with hydrophilic polymers or washing with buffered solutions to obtain the coated or washed retainer. The coated retainer still showed a burst release while the washed retainer showed an optimal sustained release. Many CH microparticles existed on the surface of original retainers according to the scanning electron microscopic image so that the burst release was unavoidable. The hydrophilic polymer coating method did not change the release profile because the polymer was also rapidly dissolved. However, most of the surface CH can be eliminated by washing so that the burst release dissappeared in the washed retainer. Furthermore, the simulated CH concentration-time profiles in the circulation of humans of the washed retainer showed the stable and appropriate drug levels for more than 3 days. Wearable personalized 3D printed drug-loaded orthodontic retainers are a promising drug-device for sustained release of drugs.